Synthesis of indenoisoquinolines

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07495100

ABSTRACT:
Indenoisoquinolines and dihydroindenoisoquinolines are described. In particular, such compounds possessing one or more electron withdrawing substituents are described. The in vitro anticancer activities of these molecules tested in the National Cancer Institute's screen of 55 cell lines is described. The compounds tested for topoisomerase I (top1) inhibition is described.

REFERENCES:
patent: 5597831 (1997-01-01), Michalsky et al.
patent: 6509344 (2003-01-01), Cushman et al.
patent: WO 00/21537 (2000-04-01), None
patent: WO 01/30753 (2001-05-01), None
patent: WO 03/051289 (2003-06-01), None
patent: WO 2004/014862 (2004-02-01), None
patent: WO 2004/014906 (2004-02-01), None
patent: WO 2004/014918 (2004-02-01), None
Cushman et al., “Stereoselective Oxidation by Thionyl Chloride Leading to the Indeno[1,2-c]isoquinoline System,”J. Org. Chem., 1978, vol. 43, No. 19, pp. 3781-3783.
Cushman et al., “Total Synthesis of Nitidine Chloride,”J. Org. Chem., 1978, vol. 43, No. 2, pp. 286-288.
Cushman et al., “Synthesis of New Indeno[1,2-c]isoquinolines: Cytotoxic Non-Camptothecin Topoisomerase I Inhibitors,”J. Med. Chem., 2000, vol. 43, No. 20, pp. 3688-3698.
Kohlhagen et al., “Protein-Linked DNA Strand Breaks Induced by NSC 314622, a Novel Noncamptothecin Topoisomerase I Poison,”Mol. Pharmacol., 1998, vol. 54, pp. 50-58.
Staker et al., “The Mechanism of Topoisomerase I Poisoning by a Camptothecin Analog,”Proc. Natl. Acad. Sci. U.S.A., 2002, vol. 99, No. 24, pp. 15387-15392.
Nagarajan et al., “Design, Synthesis, and Biological Evaluation of Indenoisoquinoline Topoisomerase I Inhibitors Featuring Polyamine Side Chains on the Lactam Nitrogen,”J. Med. Chem., 2003, vol. 46, No. 26, pp. 5712-5724.
Shetty et al., “Aromatic π-Stacking in Solution as Revealed through the Aggregation of Phenylacetylene Macrocycles,”J. Am. Chem. Soc., 1996, vol. 118, No. 5, pp. 1019-1027.
Vance et al., “Structural Features of Nitroaromatics That Determine Mutagenic Activity inSalmonella typhimurium,” Environmental Mutagenesis, 1984, vol. 6, pp. 797-811.
Whitmore et al., “The Preparation of Homophthalyl Cyclic Hydrazide and 4-Aminohomophthalyl Cyclic Hydrazide,”J. Am. Chem. Soc., 1944, vol. 66, pp. 1237-1240.
Strumberg et al., “Synthesis of Cytotoxic Indenoisoquinoline Topoisomerase I Poisons,”J. Med. Chem., 1999, vol. 42, No. 3, pp. 446-457.
Nagarajan et al., “Synthesis and Anticancer Activity of Simplified Indenoisoquinoline Topoisomerase I Inhibitors Lacking Substituents on the Aromatic Rings,”J. Med. Chem., 2004, vol. 47, No. 23, pp. 5651-5661.
Jayaraman et al., “Synthesis of New Dihydroindeno[1,2-c]isoquinoline and Indenoisoquinolinium Chloride Topoisomerase I Inhibitors Having High In Vivo Anticancer Activity in the Hollow Fiber Animal Model,”J. Med. Chem., 2002, vol. 45, No. 1, pp. 242-249.
Fox et al., “Design, Synthesis, and Biological Evaluation of Cytotoxic 11-Alkenylindenoisoquinoline Topoisomerase I Inhibitors and Indenoisoquinoline-Camptothecin Hybrids,”J. Med. Chem., 2003, vol. 46, No. 15, pp. 3275-3282.
Kubova et al., “Binding Properties of Nitidine and Its Indenoisoquinoline Analogue with DNA,”Studia Biophs., 1986, vol. 114, No. 1-3, pp. 251-256.
Anthony et al., “Differential Induction of Topoisomerase I-DNA Cleavage Complexes by the Indenoisoquinoline MJ-III-65 (NSC 706744) and Camptothecin: Base Sequence Analysis and Activity Against Camptothecin-Resistant Topoisomerase I,”Cancer Res., 2003, vol. 63, pp. 7428-7435.
Cho et al., “A Novel Synthesis of Benzo[c]phenanthridine Skeleton and Biological Evaluation of Isoquinoline Derivatives,”Chem. Pharm. Bull. vol. 47, No. 6, pp. 900-902 (1999).
Shamma et al., “Synthetic Approaches to Camptothecin,”Tetrahedron, vol. 25, pp. 2275-2279 (1969).
Dyke et al., “The Chemistry of Cryptopine-I: The Epicryptopines,”Tetrahedron, vol. 24, pp. 1455-1465 (1968).
Cushman et al., “Synthesis and Antitumor Activity of Structural Analogues of the Anticancer Benzophenanthridine Alkaloid Fagaronine Chloride,”J. Med. Chem., 1985, vol. 28, No. 8, pp. 1031-1036.
Wawzonek et al., “The Synthesis and Reactions of 1-Carbamyl-11-ketoindeno[1,2-c]isoquinoline,”J. Org. Chem., 1966, vol. 31, pp. 1004-1006.
Patel et al., “Neuromuscular blocking activity ofbis-4-benzyltetrahydroisoquinolinium esters in the cat,”European Journal of Pharmaceutical Sciences, vol. 4 (1996), 63-71.
Corey et al., “A Total Synthesis of Natural 20(S)-Camptothecin,”J. Org. Chem., vol. 40, No. 14, 1975, pp. 2140-2141.
Xiao et al., “Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines,”Bioorganic&Medicinal Chemistry Letters, vol. 15 (2005), 2795-2798.
Staker et al., “Structures of Three Classes of Anticancer Agents Bound to the Human Topoisomerase I-DNA Covalent Complex,”J. Med. Chem., 2005, vol. 48, No. 7, 2336-2345.
Ioanoviciu et al., “Synthesis and Mechanism of Action Studies of a Series of Norindenoisoquinoline Topoisomerase I Poisons Reveal an Inhibitor with a Flipped Orientation in the Ternary DNA-Enzyme-Inhibitor Complex As Determined by X-ray Crystallographic Analysis,”J. Med. Chem., 2005, vol. 48, No. 15, 4803-4814.
Xiao et al., “On the Binding of Indeno[1,2-c]isoquinolines in the DNA-Topoisomerase I Cleavage Complex,”J. Med. Chem., 2005, vol. 48, No. 9, 3231-3238.
Antony et al., “Cellular Topoisomerase I Inhibition and Antiproliferative Activity by MJ-III-65 (NSC 706744), an Indenoisoquinoline Topoisomerase I Poison,”Molecular Pharmacology, 2005, vol. 67, No. 2, 523-530.
Hertzberg et al., “On the Mechanism of Topoisomerase I Inhibition by Camptothecin: Evidence for Binding to an Enzyme-DNA Complex,”Biochemistry, 1989, vol. 28, No. 11, 4629-4638.
Wang et al., “Differential Effects of Camptothecin Derivatives on Topoisomerase I-Mediated DNA Structure Modification,”Biochemistry, 1998, vol. 37, No. 26, 9399-9408.
Wang et al., “Role of the 20-Hydroxyl Group in Camptothecin Binding by the Topoisomerase I-DNA Binary Complex,”Biochemistry, 1999, vol. 38, No. 14, 4374-4381.
Morrell et al., “Synthesis of nitrated indenoisoquinoles as topoisomerase I inhibitors,”Bioorganic&Medicinal Chemistry Letters, vol. 14 (2004), 3659-3663.
Xiao et al., “Design, synthesis, and biological evaluation of cytotoxic 11-aminoalkenylindenoisoquinoline and 11-diaminoalkenylindenoisoquinoline topoisomerase I inhibitors,”Bioorganic&Medicinal Chemistry, vol. 12 (2004), 5147-5160.
Pourquier et al., “Induction of Reversible Complexes between Eukaryotic DNA Topoisomerase I and DNA-containing Oxidative Base Damages,”The Journal of Biological Chemistry, vol. 274, No. 13, 1999, pp. 8516-8523.
Cushman et al., “Synthesis and Biological Activity of Structural Analogues of the Anticancer Benzophenanthridine Alkaloid Nitidine Chloride,”J. Med. Chem., 1984, vol. 27, No. 4, 544-547.
Hertzerg et al., “Modification of the Hydroxy Lactone Ring of Camptothecin: Inhibition of Mammalian Topoisomerase I and biological Activity,”J. Med. Chem., 1989, vol. 32, No. 3, 715-720.
Somekawa et al., “Intramolecular [2+2]Photocycloadditions of 1-(ω-Alkenyl)-2-pyridones Possessing an Ester Group on the Olefinic Carbon Chain,”J. Org. Chem., 1992, vol. 57, No. 21, 5708-5712.
Canan Koch et al, “Enantioselective Preparation of β-Alkyl-γ-butyrolactones from Functionalized Ketene. Dithioacetals,”J. Org. Chem., 1993, vol. 58, No. 10, 2725-2737.
Jayaraman et al., “Novel Oxidative Transformation of Indenoisoquinolines to Isoquinoline-3-spiro-3′-phthalides in the Presence of Osmium Tetraoxide and 4-methylmorpholineN-Oxide,”J. Org. Chem., 1998, vol. 63, No. 17, 5736-5737.
Xiao et al., “Novel Au

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Synthesis of indenoisoquinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthesis of indenoisoquinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis of indenoisoquinolines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4084930

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.